Blue Owl amends Schedule 13G for Repare Therapeutics (NASDAQ: RPTX)

Rhea-AI Filing Summary

Repare Therapeutics Inc. — Blue Owl Capital Holdings LP filed Amendment No. 2 to a Schedule 13G/A reporting beneficial ownership of 5 percent or less of the company's common shares. The statement references cover-page rows for the exact share and percentage figures and is signed by Karen Hager, Chief Compliance Officer.

Insights

Institutional Ownership Analyst

Amendment confirms a passive stake at or below 5%.

The amendment states the filer holds "5 percent or less of a class," a common threshold that distinguishes passive Schedule 13G reporting from active 13D disclosures. Exact share and percentage counts are referenced on the cover-page rows rather than in the body of the excerpt.

Institutional filings at this threshold typically imply passive monitoring; subsequent filings would show any material increases above 5 percent that could change disclosure status.

Key Figures

Reported ownership threshold: 5 percent or less CUSIP: 760273102 Cover-page date referenced: 03/31/2026 +1 more

4 metrics

Reported ownership threshold 5 percent or less ownership of common shares as stated in Item 5

CUSIP 760273102 Common shares CUSIP on cover page

Cover-page date referenced 03/31/2026 date shown near cover-page header

Signature date 05/13/2026 date of signature by Karen Hager

Key Terms

Schedule 13G/A, Beneficial ownership, CUSIP

3 terms

Schedule 13G/A regulatory

"Amendment No. 2 to Schedule 13G/A reporting beneficial ownership"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficial ownership financial

"Item 4. Ownership (a) Amount beneficially owned"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

CUSIP financial

"Common shares, no par value 760273102"

A CUSIP is a nine-character alphanumeric code that uniquely identifies a U.S. or Canadian financial security—such as a stock, bond, or fund share—like a Social Security number for an investment. It matters to investors because brokers, exchanges and record-keepers use the CUSIP to match trades, track ownership, settle transactions and pull accurate records, reducing errors and ensuring money and securities go to the right place.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 04:27 PM Learn about SEC filing dates

FAQ

What does Blue Owl report for RPTX in this 13G/A amendment?

Blue Owl reports beneficial ownership of 5 percent or less of Repare Therapeutics common shares. The amendment references cover-page rows for the precise share count and percentage and is executed by the filer’s Chief Compliance Officer.

Does the amendment disclose the exact share count for RPTX?

The amendment points to cover-page rows for the exact share count and percentage rather than listing them in the body. The filing includes a CUSIP 760273102 and references those cover-page fields for numeric detail.

Who filed the Schedule 13G/A amendment for RPTX?

The filing was made by Blue Owl Capital Holdings LP and signed by Karen Hager in her capacity as Chief Compliance Officer. The cover-page identifies the filing entity and its principal business address in New York.

What reporting status does holding "5 percent or less" imply for RPTX?

Holding "5 percent or less" is consistent with passive investor reporting under Schedule 13G rather than an active 13D disclosure. Any increase above that threshold would typically trigger different reporting obligations.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 2)

Repare Therapeutics Inc.

(Name of Issuer)

Common shares, no par value

(Title of Class of Securities)

760273102

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 760273102

1

Names of Reporting Persons

Blue Owl Capital Holdings LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

0.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.00 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Repare Therapeutics Inc.
(b)	Address of issuer's principal executive offices: 7171 Frederick Banting, Building 2, Suite 270, Saint-Laurent, Quebec, Canada H4S 1Z9
Item 2.
(a)	Name of person filing: This statement is filed by Blue Owl Capital Holdings LP.
(b)	Address or principal business office or, if none, residence: 399 Park Avenue, New York, New York 10022
(c)	Citizenship: See response to row 4 on the cover page.
(d)	Title of class of securities: Common shares, no par value
(e)	CUSIP No.: 760273102
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to row 9 on the cover page.
(b)	Percent of class: See response to row 11 on the cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to row 5 on the cover page.
	(ii) Shared power to vote or to direct the vote: See response to row 6 on the cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to row 7 on the cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to row 8 on the cover page.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Blue Owl Capital Holdings LP

Signature:	/s/ Karen Hager
Name/Title:	Karen Hager / Chief Compliance Officer
Date:	05/13/2026